Stay updated on Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A consolidated 'Locations' section listing all study sites by country and city was added. The page's location subsections were reorganized to a single listing.
    Difference
    3%
    Check dated 2025-12-22T01:54:47.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.3.1 was removed from the page header.
    Difference
    0.0%
    Check dated 2025-11-30T15:43:24.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    - Revision updated to v3.3.1 from v3.2.0; this appears to be a backend version update with no visible changes to study content or layout.
    Difference
    0.0%
    Check dated 2025-11-23T14:51:05.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Removed a generic government funding status notice from the ClinicalTrials.gov page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-16T14:22:10.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the Study Details page for NCT04210843.
    Difference
    0.1%
    Check dated 2025-11-02T00:46:32.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    - Added a government funding notice and operating status details (critical for user awareness). - Bumped version from v3.1.0 to v3.2.0 (metadata-level update).
    Difference
    1%
    Check dated 2025-10-04T12:34:27.000Z thumbnail image

Stay in the know with updates to Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.